Medical Care Technologies (OTC: MDCE) Unveils Bold Vision for Mobile Self-Care Innovation
Medical Care Technologies (OTC: MDCE) has launched its official website, showcasing its strategic focus on AI-powered mobile health diagnostics and self-care solutions. The company has developed several patent-pending innovations leveraging smartphone technology for health monitoring, including an AI Wound-Healing Monitor, Mental Health Scanner, Health Risk Estimator, and Mole Lineage Tracker.
These technologies originated from MDCE's subsidiary, Real Game Used, adapting their image authentication software for healthcare applications. The company plans to launch a beta app in 2026 and is pursuing multiple patent applications to advance its mission of making preventive healthcare accessible through mobile devices.
Medical Care Technologies (OTC: MDCE) ha lanciato il suo sito web ufficiale, evidenziando il suo focus strategico su diagnostica mobile basata sull'intelligenza artificiale e soluzioni di auto-cura. L'azienda ha sviluppato numerose innovazioni in attesa di brevetto che sfruttano la tecnologia degli smartphone per il monitoraggio della salute, tra cui un Monitor AI per la Guarigione delle Ferite, uno Scanner per la Salute Mentale, uno Stimatore del Rischio per la Salute e un Tracciatore della Linea dei Nei.
Queste tecnologie derivano dalla controllata di MDCE, Real Game Used, che ha adattato il proprio software di autenticazione delle immagini per applicazioni sanitarie. L'azienda prevede di lanciare una app beta nel 2026 e sta seguendo diverse domande di brevetto per portare avanti la sua missione di rendere la prevenzione sanitaria accessibile tramite dispositivi mobili.
Medical Care Technologies (OTC: MDCE) ha lanzado su sitio web oficial, mostrando su enfoque estratégico en diagnósticos móviles impulsados por IA y soluciones de autocuidado. La compañía ha desarrollado varias innovaciones pendientes de patente que aprovechan la tecnología de los smartphones para el monitoreo de la salud, incluyendo un Monitor de Cicatrización de Heridas con IA, un Escáner de Salud Mental, un Estimador de Riesgos para la Salud y un Rastreador de Linaje de Lunares.
Estas tecnologías provienen de la subsidiaria de MDCE, Real Game Used, que adaptó su software de autenticación de imágenes para aplicaciones en salud. La empresa planea lanzar una app beta en 2026 y está gestionando múltiples solicitudes de patente para avanzar en su misión de hacer que la atención preventiva sea accesible a través de dispositivos móviles.
Medical Care Technologies (OTC: MDCE)가 공식 웹사이트를 개설하여 AI 기반 모바일 건강 진단 및 자기 관리 솔루션에 대한 전략적 집중을 선보였습니다. 이 회사는 스마트폰 기술을 활용한 건강 모니터링을 위해 여러 특허 출원 중인 혁신 기술을 개발했으며, 여기에는 AI 상처 치유 모니터, 정신 건강 스캐너, 건강 위험 평가기, 점(lineage) 추적기가 포함됩니다.
이 기술들은 MDCE의 자회사인 Real Game Used에서 시작되었으며, 이미지 인증 소프트웨어를 의료 분야에 맞게 조정한 것입니다. 회사는 2026년에 베타 앱 출시를 계획하고 있으며, 모바일 기기를 통한 예방 의료 접근성을 높이기 위해 여러 특허 출원을 진행 중입니다.
Medical Care Technologies (OTC : MDCE) a lancé son site officiel, mettant en avant son orientation stratégique vers des diagnostics mobiles basés sur l'IA et des solutions d'autosoins. La société a développé plusieurs innovations en attente de brevet utilisant la technologie des smartphones pour la surveillance de la santé, notamment un Moniteur de Cicatrisation des Plaies par IA, un Scanner de Santé Mentale, un Estimateur de Risques Sanitaires et un Suiveur de Lignée de Grain de Beauté.
Ces technologies proviennent de la filiale de MDCE, Real Game Used, qui a adapté son logiciel d'authentification d'images aux applications médicales. La société prévoit de lancer une application bêta en 2026 et poursuit plusieurs demandes de brevet pour faire avancer sa mission de rendre la prévention santé accessible via les appareils mobiles.
Medical Care Technologies (OTC: MDCE) hat seine offizielle Website gestartet und präsentiert seinen strategischen Fokus auf KI-gestützte mobile Gesundheitsdiagnostik und Selbstfürsorgelösungen. Das Unternehmen hat mehrere patentierte Innovationen entwickelt, die Smartphone-Technologie für die Gesundheitsüberwachung nutzen, darunter einen KI-Wundheilungsmonitor, einen Mental Health Scanner, einen Gesundheitsrisikoschätzer und einen Muttermal-Linienverfolger.
Diese Technologien stammen von MDCEs Tochtergesellschaft Real Game Used, die ihre Bildauthentifizierungssoftware für Gesundheitsanwendungen angepasst hat. Das Unternehmen plant, 2026 eine Beta-App zu starten und verfolgt mehrere Patentanmeldungen, um seine Mission voranzutreiben, präventive Gesundheitsversorgung über mobile Geräte zugänglich zu machen.
- None.
- Products still in development phase with no current revenue
- Beta app launch not until 2026 indicating long path to commercialization
- Trading on OTC Pink Market which typically indicates higher risk
Empowering Everyday Health Through AI: MDCE Launches Official Site
MESA, AZ / ACCESS Newswire / July 7, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a health technology company focused on AI-powered self-care and mobile diagnostics, is proud to announce the launch of its official website at www.medicalcaretechnologies.com. The new platform highlights the company's strategic mission to deliver transformative, AI-driven health solutions accessible via smartphone-bringing early detection and preventive medicine directly into the hands of users worldwide.
The company's growing portfolio of patent-pending innovations includes:
AI Wound-Healing Monitor: Uses sequential smartphone images to assess chronic wound recovery with clinical-level precision.
AI Micro-Expression Mental Health Scanner: Detects early signs of depression, anxiety, and PTSD using facial pattern analysis from short selfie videos.
Facial Age-Based Health Risk Estimator: Estimates biological age and predicts chronic disease risk from a single facial photo.
AI Mole Lineage Tracker: Tracks changes in skin lesions over time using full-body photo mapping to support melanoma detection.
Each technology was originally developed under MDCE's subsidiary, Real Game Used, whose image analysis engine was adapted from authentication software used in elite memorabilia verification. The company is now applying that high-resolution, image-intelligent foundation to solve critical problems in healthcare, chronic disease monitoring, and early risk detection.
"Our goal is simple but ambitious as this project has been in the works for over a year," said a spokesperson for MDCE. "We're building powerful health tools that anyone can use-from their pocket-before symptoms become crises. With plans for multiple patent applications underway and a planned beta app launch in 2026, we believe our model has the potential to redefine self-care and reshape the future of AI in preventive medicine."
Medical Care Technologies Inc. trades on the OTC Pink Market under the ticker MDCE and operates with a growing pipeline of strategic partnerships. The company invites investors, partners, and healthcare innovators to explore its newly launched digital home.
Visit: www.medicalcaretechnologies.com
About Medical Care Technologies Inc. (OTC: MDCE)
Medical Care Technologies is an AI-driven health innovation company focused on delivering mobile-first, diagnostic-grade wellness tools. By combining deep learning, computer vision, and personalized analytics, MDCE empowers individuals to monitor their health using only a smartphone. The company's mission is to bring preventive care to life through accessible, intelligent technology.
Safe Harbor Statement:
This press release may contain forward-looking statements subject to risks and uncertainties. Actual results may differ materially from those expressed or implied. The company undertakes no obligation to update forward-looking statements, except as required by law.
Media & Investor Contact:
Infinite Auctions / Medical Care Technologies
info@medicalcaretechnologies.com
www.medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
What AI health technologies is Medical Care Technologies (MDCE) developing?
When will MDCE's health monitoring app be available to the public?
How does MDCE's technology work with smartphones?
What is the background of MDCE's AI technology?
Where can investors find more information about Medical Care Technologies (MDCE)?
